Latest News

One-year data from VenoValve US pivotal trial emerges

Envveno Medical has announced that it will present one-year data on all patients from the VenoValve US pivotal trial today at the VEITHsymposium (19–23 November, New York,...

From the Editor

Who harmed who?

In his address at the 2024 Vascular Annual Meeting (VAM), Society for Vascular Surgery Immediate Past President Joseph Mills, MD, eloquently stated—and please excuse...

The CLTI conundrum: My spirited journey through the CLTI saga

Welcome to the CLTI Chronicles, a saga of mystery, medi­cine and misadventures in limb salvage unfolding weekly in my office, where the drama of...

SVS news

Review with VESAP6

The sixth edition of the Vascular Education and Self-Assessment Program (VESAP6) is available for both members and nonmembers of the SVS to purchase. The...

‘Voices of Vascular’ series celebrates Ochoa for Hispanic History Month

The SVS Foundation “Voices of Vascular” series is celebrating Lyssa Ochoa, MD, for this year’s Hispanic History Month. A Mexican American vascular surgeon, Ochoa is...

Commentary

Hospitals represent one of the largest industries in the U.S., with revenues greater than $1.4 trillion. The American Hospital Association reports that there are 5,200 nonfederal, short-term general, and other special hospitals in the country, of which 3,000 are...

VAM news

Vascular surgeon-scientists may submit their research for presentation at the 2025 Vascular Annual Meeting (VAM) in June starting from Nov. 6 through Wednesday, Jan. 8, 2025.  VAM research—both clinical and translational—is considered for presentation in several different forums that appeal...

Most read

From the editor

Commentary